MONITORING UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS BY FRAILTY STATUS

被引:0
|
作者
Gopalakrishnan, Chandrasekar [1 ,2 ]
Kim, Dae [3 ]
Kutz, Alexander [4 ]
Patorno, Elisabetta [1 ,2 ]
机构
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Hebrew SeniorLife, Boston, MA USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:208 / 208
页数:1
相关论文
共 50 条
  • [1] UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS WITH AND WITHOUT DEMENTIA
    Gopalakrishnan, Chandrasekar
    Kim, Dae
    Patorno, Elisabetta
    INNOVATION IN AGING, 2022, 6 : 468 - 469
  • [2] Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes
    Bilal, Anika
    Pratley, Richard E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (02) : 355 - 375
  • [3] Glucose-Lowering Drugs and Risk of COPD Exacerbations in Adults with Type 2 Diabetes
    Ray, Avik
    Paik, Julie M.
    Feldman, William B.
    Sreedhara, Sushama Kattinakere
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2024, 73
  • [4] Future glucose-lowering drugs for type 2 diabetes
    Bailey, Clifford J.
    Tahrani, Abd A.
    Barnett, Anthony H.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (04): : 350 - 359
  • [5] Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities
    Doucet, Jean
    Gourdy, Pierre
    Meyer, Laurent
    Benabdelmoumene, Nabil
    Bourdel-Marchasson, Isabelle
    CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 1687 - 1703
  • [6] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
    Kabadi, Udaya M.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 140 - 140
  • [7] Trial Compares Glucose-Lowering Drugs for Type 2 Diabetes
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (16): : 1581 - 1581
  • [8] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes RESPONSE
    Tsapas, Apostolos
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Matthews, David R.
    Bekiari, Eleni
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 141 - 141
  • [9] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1248 - 1260
  • [10] Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ferrannini, Ele
    DeFronzo, Ralph A.
    EUROPEAN HEART JOURNAL, 2015, 36 (34) : 2288 - U19